Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Ruxuan Li"'
Autor:
Sanghoon Lee, Youngbin Cho, Yiting Li, Ruxuan Li, Angela Wong Lau, Matthew S. Laird, Daniel Brown, Priscilla McAuliffe, Adrian V. Lee, Steffi Oesterreich, Ioannis K. Zervantonakis, Hatice Ulku Osmanbeyoglu
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
Macrophages are pivotal in driving breast tumor development, progression, and resistance to treatment, particularly in estrogen receptor-positive (ER+) tumors, where they infiltrate the tumor microenvironment (TME) influenced by cancer cell-secreted
Externí odkaz:
https://doaj.org/article/4bfdd076a36646f688b1e338892c683e
Autor:
Youngbin Cho, Matthew S. Laird, Teddi Bishop, Ruxuan Li, Dorota E. Jazwinska, Elisa Ruffo, Jason Lohmueller, Ioannis K. Zervantonakis
Publikováno v:
APL Bioengineering, Vol 8, Iss 3, Pp 036105-036105-13 (2024)
The success of chimeric antigen receptor (CAR) T cells in blood cancers has intensified efforts to develop CAR T therapies for solid cancers. In the solid tumor microenvironment, CAR T cell trafficking and suppression of cytotoxic killing represent l
Externí odkaz:
https://doaj.org/article/2c29e5f014ed49e092416876e4d39004
Publikováno v:
Applied Mathematical Modelling. 111:644-663
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89f8a344f0d4be32c54fe9f7efcb3376
https://doi.org/10.1016/j.apm.2022.07.013
https://doi.org/10.1016/j.apm.2022.07.013
Autor:
Ioannis K. Zervantonakis, Triantafyllos Stylianopoulos, Gordon B. Mills, Ruxuan Li, Maria Kalli
Supplementary Data from Mechanical Stress Signaling in Pancreatic Cancer Cells Triggers p38 MAPK- and JNK-Dependent Cytoskeleton Remodeling and Promotes Cell Migration via Rac1/cdc42/Myosin II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b65f6b0b79d61cad5a1320941e7ef42
https://doi.org/10.1158/1541-7786.22527870.v1
https://doi.org/10.1158/1541-7786.22527870.v1
Autor:
Ioannis K. Zervantonakis, Maria Kalli, Gordon B. Mills, Triantafyllos Stylianopoulos, Ruxuan Li
Publikováno v:
Mol Cancer Res
Molecular Cancer Research
Molecular Cancer Research
Advanced or metastatic pancreatic cancer is highly resistant to existing therapies, and new treatments are urgently needed to improve patient outcomes. Current studies focus on alternative treatment approaches that target the abnormal microenvironmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a025173c84df54af61d1aa34d7ea2c9
https://doi.org/10.1158/1541-7786.mcr-21-0266
https://doi.org/10.1158/1541-7786.mcr-21-0266
Publikováno v:
Engineering and Physical Approaches to Cancer ISBN: 9783031228018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a2790c2518e90b12e5b7153b9442515
https://doi.org/10.1007/978-3-031-22802-5_7
https://doi.org/10.1007/978-3-031-22802-5_7
Publikováno v:
Cancer Research. 83:4613-4613
Among all breast cancer subtypes, triple-negative breast cancer (TNBC) exhibits the least favorable outcomes with a complex tumor microenvironment that facilitates metastatic progression. Remodeling of the extracellular matrix at the tumor invasive f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e944219660e568c464e8ab68326cd7a
https://doi.org/10.1158/1538-7445.am2023-4613
https://doi.org/10.1158/1538-7445.am2023-4613
Autor:
Ruxuan Li, Xingwei Yan
Publikováno v:
2022 International Conference on Advanced Mechatronic Systems (ICAMechS).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf3af243c41f28926acd4bf9fcd0cf54
https://doi.org/10.1109/icamechs57222.2022.10003285
https://doi.org/10.1109/icamechs57222.2022.10003285
Autor:
Xingwei Yan, Ruxuan Li
Publikováno v:
2022 International Conference on Advanced Mechatronic Systems (ICAMechS).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4680d8919e71f4f98412d238c37f3c4
https://doi.org/10.1109/icamechs57222.2022.10003278
https://doi.org/10.1109/icamechs57222.2022.10003278
Publikováno v:
Cancer Research. 82:6349A-6349A
INTRODUCTION: One of the most fundamental problems that oncologists are currently facing in pancreatic cancer patient care is the high resistance to all types of chemotherapies or targeted therapies. Thus, there is an urgent need for increasing patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85e0cbdc5a5a7565827c3214b3f02d44
https://doi.org/10.1158/1538-7445.am2022-6349a
https://doi.org/10.1158/1538-7445.am2022-6349a